CVS Health Pharmacy Services — Revenue decreased by 5.0% to $100.43B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 6.2%, from $94.59B to $100.43B. Over 3 years (FY 2020 to FY 2025), Pharmacy Services — Revenue shows an upward trend with a 24.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Growth indicates expansion in market share, higher drug pricing, or increased volume of claims processed, while a decline may signal loss of contracts or pricing pressure.
The total gross revenue generated by the Pharmacy Services segment from all sources, including intersegment and external...
Standard revenue metric for PBMs and pharmacy service providers; comparable to top-line segment reporting at major healthcare distributors.
cvs_segment_pharmacy_services_revenues| Q2 '21 | Q2 '21 | Q3 '21 | Q3 '21 | Q4 '21 | Q4 '21 | Q1 '22 | Q1 '22 | Q2 '22 | Q2 '22 | Q3 '22 | Q3 '22 | Q4 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $72.62B | $38.31B | $73.79B | $39.05B | $76.60B | $39.34B | $76.83B | $39.46B | $80.64B | $42.81B | $81.16B | $43.22B | $83.85B | $43.75B | $85.28B | $88.92B | $89.76B | $93.81B | $88.44B | $91.23B | $95.43B | $97.71B | $94.59B | $98.92B | $102.87B | $105.69B | $100.43B |
| QoQ Change | — | -47.2% | +92.6% | -47.1% | +96.2% | -48.6% | +95.3% | -48.6% | +104.3% | -46.9% | +89.6% | -46.8% | +94.0% | -47.8% | +94.9% | +4.3% | +0.9% | +4.5% | -5.7% | +3.2% | +4.6% | +2.4% | -3.2% | +4.6% | +4.0% | +2.7% | -5.0% |
| YoY Change | — | — | — | — | — | — | — | — | +11.0% | -41.0% | +10.0% | -41.4% | +9.5% | -42.9% | +11.0% | +10.3% | +10.6% | +11.9% | +3.7% | +2.6% | +6.3% | +4.2% | +7.0% | +8.4% | +7.8% | +8.2% | +6.2% |